文献速递男科与性医学

不育男性死亡风险升高:美国医保理赔数据分析

Increased Mortality Among Men Diagnosed With Impaired Fertility: Analysis of US Claims Data.
PubMed 文献 · Urology · 2020-10-02

基于美国Optum去标识化Clinformatics Data Mart数据库2003至2017年数据,比较134,796例不育男性与242,282例接受精液分析对照者的死亡风险。不育男性总体死亡风险升高(HR=1.42,95%CI 1.27-1.60),无精子症者风险更高(HR=2.01,95%CI 1.60-2.53),排除已患心血管病和恶性肿瘤后结果相似。

要点

  • 不育男性总体死亡风险升高,无精子症者风险约为对照的两倍。
  • 少精子症死亡风险呈升高趋势但未达统计学显著(HR=1.17,95%CI 0.92-1.49)。
  • 既往心血管病与肿瘤不能解释不育男性的超额死亡风险。

核心结论

  • 男性不育与死亡风险升高相关,无精子症男性尤为显著。
  • 常见合并疾病未能解释不育男性死亡风险的升高。

研究设计与样本

  • 基于美国Optum去标识化Clinformatics Data Mart数据库2003至2017年的理赔数据回顾性分析。
  • 不育组134,796例(含少精子症或无精子症),对照组242,282例为接受精液分析者。
  • 死亡结局通过链接社会保障局死亡主文件确定,中位随访分别为3.6年和3.1年。

主要发现

  • 不育男性总体死亡风险升高(HR=1.42,95%CI 1.27-1.60)。
  • 无精子症与死亡风险显著升高相关(HR=2.01,95%CI 1.60-2.53)。
  • 少精子症死亡风险呈升高趋势(HR=1.17,95%CI 0.92-1.49)。
  • 排除已患心血管病和恶性肿瘤后亚组分析 hazard ratio 相似。

临床怎么用

  • 对不育男性尤其是无精子症患者,评估时除生育问题外应关注整体健康与合并疾病。
  • 不育男性的治疗与随访策略是否需要调整尚需进一步研究。

局限性

  • 为理赔数据库回顾性分析,可能存在编码与混杂偏倚。
  • 平均随访约3年余,长期死亡风险未能评估。
  • 原文未报告具体并发症调整清单及亚组分析数值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether male infertility or impaired spermatogenesis is associated with mortality. METHODS: The Optum de-identified Clinformatics Data Mart database was queried from 2003 to 2017. Infertile men were compared to subjects undergoing semen analysis (ie, infertility testing). Infertile men with oligozoospermia or azoospermia were included. Mortality was determined by data linkage to the Social Security Administration Death Master File. Results were adjusted for age, smoking, obesity, year of evaluation, and health care visits as well as for most prevalent comorbidities. We separately examined men with prevalent or incident cardiovascular disease and cancer diagnoses to determine associations with mortality. RESULTS: A total of 134,796 infertile men and 242,282 controls were followed for a mean of 3.6 and 3.1 years respectively. Overall, infertile men had a higher risk of death (Hazard Ratio [HR]= 1.42, 95% CI: 1.27-1.60) The diagnosis of azoospermia was associated with a significantly increased risk of death (HR= 2.01, 95% CI: 1.60-2.53) with a higher trend among men with oligospermia (HR: 1.17, 95% CI: 0.92-1.49) compared to controls. Subanalysis was done excluding prevalent cardiovascular and malignant disease (alone and combined) showing similar hazard ratios. CONCLUSION: Male infertility is associated with a higher risk of mortality especially among azoospermic men. Prevalent disease (which is known to be higher among infertile men) did not explain the higher risk of death among infertile men. The implications for treatment and surveillance of infertile men require further study.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Del Giudice F, Kasman AM, Li S, et al. Increased Mortality Among Men Diagnosed With Impaired Fertility: Analysis of US Claims Data. Urology. 2020. PMID: 33017614. doi:10.1016/j.urology.2020.07.087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。